PHUSE Single Day Event – Back to the Future of Clinical Trials: Navigating the Ever-Changing Landscape When Conducting Clinical Research Conference PHUSE Single Day Event – Back to the Future of Clinical Trials: Navigating the Ever-Changing Landscape When Conducting Clinical Research CertaraJuly 19, 2024
What is a scientific & medical publications professional? Blog What is a scientific & medical publications professional? Would your drug development program benefit from partnering with experts in scientific and medical communications…CertaraJuly 19, 2024
Technical debt in software ownership and SaaS Blog Technical debt in software ownership and SaaS Technical debt is unavoidable. How do you mitigate associated risks?CertaraJuly 19, 2024
Inclusion of Obese Participants in Drug Development: Reflections on the Current Landscape and a Call for Action Publication Inclusion of Obese Participants in Drug Development: Reflections on the Current Landscape and a Call for Action CertaraJuly 17, 2024
Extended Model-Informed Drug Development: Beyond Clinical Trials and Regulatory Approval Publication Extended Model-Informed Drug Development: Beyond Clinical Trials and Regulatory Approval CertaraJuly 16, 2024
New feature release: Reaction enumeration in Design Hub Blog New feature release: Reaction enumeration in Design Hub New Feature Release: Reaction Enumeration in Design HubCertaraJuly 16, 2024
Pinnacle 21 Enterprise analytics: Case studies from the field Blog Pinnacle 21 Enterprise analytics: Case studies from the field In this blog, we look at some examples of how Pinnacle 21 Enterprise Analytics (P21E)…CertaraJuly 15, 2024
Comparative pharmacokinetics of a single oral dose of meloxicam in the California sea lion (Zalophus californianus) and Pacific harbor seal (Phoca vitulina richardii) Publication Comparative pharmacokinetics of a single oral dose of meloxicam in the California sea lion (Zalophus californianus) and Pacific harbor seal (Phoca vitulina richardii) Explore how both pinniped species show long meloxicam half‑lives, suggesting dosing interval reconsideration, modelled using…CertaraJuly 14, 2024